Trials / Conditions / Respiratory Tract Infection

Respiratory Tract Infection

27 registered clinical trials studyying Respiratory Tract Infection — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), F NCT07149428	National Institute on Deafness and Other Communication Disorders (NIDCD)	—
Completed	This Study Evaluated the Safety of Awake Extubation in Children at Risk for Respiratory Events Undergoing Gene NCT06936761	Selcuk University	—
Completed	SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS NCT06482099	Pfizer	—
Completed	Immunomodulatory Effect of Pleuran in Children With Recurrent Respiratory Tract Infections NCT06974747	Pleuran, s.r.o.	N/A
Completed	A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China NCT05337163	Creative Biosciences (Guangzhou) Co., Ltd.	—
Completed	A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. NCT04424316	Pfizer	Phase 3
Completed	A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEAR NCT04071158	Pfizer	Phase 2
Completed	A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOM NCT04032093	Pfizer	Phase 2
Completed	Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002) NCT03524118	Merck Sharp & Dohme LLC	Phase 1 / Phase 2
Terminated	A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults NCT03572062	Pfizer	Phase 2
Unknown	A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients NCT02087761	Luminex Corporation	—
Unknown	Prolonged Infusion Cefepime and Nosocomial Infections NCT02568800	Hospital de Clinicas de Porto Alegre	Phase 3
Completed	A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel NCT01787227	Luminex Molecular Diagnostics	—
Completed	Impact of Respiratory Pathogens in Infants NCT01789268	University of Rochester	—
Completed	Cholecalciferol Intervention to Prevent Respiratory Infections Study NCT01549938	Menzies Institute for Medical Research	Phase 2
Completed	Effects of a Supplement on Acute Respiratory Infections NCT02210156	Omnilife Manufactura, SA de CV	N/A
Completed	Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time NCT01075204	Abbott	—
Terminated	Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatmen NCT00934934	Daren K. Heyland	Phase 2
Completed	Home Usability of a Nasal Lavage System in Children NCT01129765	Aardvark Medical Company	—
Completed	Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR NCT01076153	Abbott	—
Completed	The Efficacy and Safety of Dexibuprofen Syrup NCT00812422	Inje University	Phase 3
Completed	Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children NCT00585481	Abbott	—
Completed	Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter NCT00688610	Hannover Medical School	Phase 2
Completed	A Three-Part Study Of GSK580416 In Healthy Subjects NCT00427141	GlaxoSmithKline	Phase 1
Completed	The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis. NCT00265187	HaEmek Medical Center, Israel	—
Completed	Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors NCT00240461	Capital Health, Canada	Phase 3
Completed	Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Tri NCT00272675	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 2 / Phase 3